{"id":3457,"date":"2008-10-24T12:49:11","date_gmt":"2008-10-24T09:49:11","guid":{"rendered":"http:\/\/www.ced.org.tr\/?p=3457"},"modified":"2008-10-24T12:49:11","modified_gmt":"2008-10-24T09:49:11","slug":"madde-12-2-recetelere-yazilabilecek-ilac-miktari","status":"publish","type":"post","link":"http:\/\/www.ced.org.tr\/?p=3457","title":{"rendered":"&#8220;MADDE 12.2. RE\u00c7ETELERE YAZILAB\u0130LECEK \u0130LA\u00c7 M\u0130KTARI&#8221;"},"content":{"rendered":"<h5 align=\"center\"><span style=\"color: black\">2008 YILI SUT &ldquo;MADDE 12.2. RE&Ccedil;ETELERE YAZILAB\u0130LECEK \u0130LA&Ccedil; M\u0130KTARI&rdquo; BA\u015eLIKLI B&Ouml;L&Uuml;MDE YAPILAN DE\u011e\u0130\u015e\u0130KL\u0130K HAKKINDA&nbsp;<\/span><\/h5>\n<p>&nbsp;<\/p>\n<p><span style=\"color: black\">2008 y\u0131l\u0131 Sa\u011fl\u0131k Uygulama Tebli\u011fi Madde 12.2&rsquo;nin 3.f\u0131kras\u0131,<\/span><span> <\/span>22 Ekim 2008 tarihinde yay\u0131mlanan <span style=\"color: black\">&ldquo;<\/span><strong><span style=\"color: black\">2008 Y\u0131l\u0131 Sosyal G&uuml;venlik Kurumu Sa\u011fl\u0131k Uygulama Tebli\u011finde De\u011fi\u015fiklik Yap\u0131lmas\u0131na Dair Tebli\u011f&rdquo; <\/span><\/strong><span style=\"color: black\">&nbsp;ile a\u015fa\u011f\u0131daki \u015fekilde d&uuml;zenlenmi\u015ftir.<\/span><\/p>\n<p style=\"margin: 0cm 0cm 0pt\" class=\"MsoNormal\">&nbsp;<\/p>\n<div style=\"border: #000 1px solid; padding: 15px\">\n<p style=\"margin: 0cm 0cm 0pt; line-height: 150%\" class=\"MsoNormal\"><strong>&ldquo;Madde 12.2. Re&ccedil;etelere yaz\u0131labilecek ila&ccedil; miktar\u0131<\/strong><\/p>\n<p style=\"margin: 0cm 0cm 0pt; line-height: 150%\" class=\"MsoNormal\"><strong>(3)<\/strong> Antiinflamatuar ve antiromatizmal grubu ila&ccedil;lar\u0131n solid-oral formlar\u0131nda b&uuml;y&uuml;k ambalaj kapsam\u0131na giren ila&ccedil;lar, ayaktan tedavide tek uzman hekim taraf\u0131ndan d&uuml;zenlenen ila&ccedil; kullan\u0131m raporuna dayan\u0131larak re&ccedil;ete edildiklerinde, en k&uuml;&ccedil;&uuml;k ambalajl\u0131 formlar\u0131 ise rapor aranmaks\u0131z\u0131n re&ccedil;ete edildiklerinde bedelleri &ouml;denir. <strong><span style=\"color: navy\">Bunlar\u0131n d\u0131\u015f\u0131nda kalan ila&ccedil;larda da ayaktan tedavide k&uuml;&ccedil;&uuml;k ambalaj verilmesi esas olup, ayn\u0131 dozda birden fazla formu olan <\/span><u><span style=\"color: red\">e\u015fde\u011fer <\/span><\/u><span style=\"color: navy\">ila&ccedil;lar\u0131n 4 haftal\u0131k tedavi dozunu ge&ccedil;en ambalaj formlar\u0131 i&ccedil;in sa\u011fl\u0131k raporu d&uuml;zenlenmesi zorunludur. &ldquo;<\/span><\/strong><\/p>\n<\/div>\n<p><span style=\"font-size: 11pt; line-height: 150%\"><\/p>\n<p>&nbsp;<\/p>\n<p><\/span><\/p>\n<p>&nbsp;<\/p>\n<p style=\"margin: 0cm 0cm 0pt; line-height: 150%\" class=\"MsoNormal\">Tebli\u011f&rsquo;de yap\u0131lan bu de\u011fi\u015fiklik sonras\u0131nda (&ouml;zel d&uuml;zenlemelere sahip ila&ccedil;lar haricinde) ayn\u0131 etken maddeyi ayn\u0131 dozda ta\u015f\u0131yan, fakat farkl\u0131 firmalar taraf\u0131ndan farkl\u0131 formlarda &uuml;retilen ila&ccedil;lar aras\u0131ndan en fazla 4 haftal\u0131k (28 g&uuml;nl&uuml;k) doza sahip olanlar\u0131n verilmesi zorunlu hale getirilmi\u015f bulunmaktad\u0131r. (Raporsuz olarak)<\/p>\n","protected":false},"excerpt":{"rendered":"<p>2008 YILI SUT &ldquo;MADDE 12.2. RE&Ccedil;ETELERE YAZILAB\u0130LECEK \u0130LA&Ccedil; M\u0130KTARI&rdquo; BA\u015eLIKLI B&Ouml;L&Uuml;MDE YAPILAN DE\u011e\u0130\u015e\u0130KL\u0130K HAKKINDA&nbsp; &nbsp; 2008 y\u0131l\u0131 Sa\u011fl\u0131k Uygulama Tebli\u011fi&#46;&#46;&#46;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-3457","post","type-post","status-publish","format-standard","hentry","category-ced"],"aioseo_notices":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[],"_links":{"self":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts\/3457","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3457"}],"version-history":[{"count":0,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts\/3457\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3457"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3457"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3457"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}